Articles, guides, and regulatory updates from our community.
New research suggests thymosin alpha-1 may improve survival in hepatitis B-related liver failure by restoring immune balance. Clinical trial data and implications.
By Peptide Association Research Team
Recent study reveals tirzepatide achieved 22.7% weight loss at 52 weeks using telehealth protocol. Learn clinical implications for peptide therapy providers.
By Peptide Association Research Team
New nanoencapsulation research reveals enhanced neuroprotection against brain injury. Learn implications for thymosin beta 4 injury treatment approaches.
By Peptide Association Research Team
New research reveals how thymosin alpha 1 immune modulation may help combat HIV latency through IL-15 pathway activation in laboratory studies.
By Peptide Association Research Team
New research reveals thymosin alpha 1 immune therapy combined with IL-15 may help reverse immune cell aging in hepatocellular carcinoma. Learn the implications.
By Peptide Association Research Team
New 2026 research explores thymosin alpha 1 immune effects on CD8 T cells. Learn what this study means for immune peptide therapy applications.
By Peptide Association Research Team
New research on SS-31 peptide reveals neuroprotective mechanisms in stroke models. Study findings on mitochondrial peptide therapy for brain health.
By Peptide Association Research Team
New research on SS-31 Elamipretide and NAC shows promising airway protection mechanisms. Learn implications for thymosin alpha 1 immune support therapy.
By Peptide Association Research Team
Breakthrough study reveals how natural compounds protect against cognitive decline through anti-inflammatory pathways. Learn implications for peptide therapy.
By Peptide Association Research Team
New research on retatrutide, a triple-agonist peptide therapy, demonstrates significant benefits for type 2 diabetes and obesity management in clinical studies.
By Peptide Association Research Team
New C. elegans study reveals Eleutheroside B's neuroprotective effects through autophagy and antioxidant mechanisms. Learn implications for peptide therapy.
By Peptide Association Research Team
Recent veterinary research on treating dry eye disease offers insights for peptide therapy providers. Find qualified doctors and learn about emerging treatments.
By Peptide Association Research Team
New study reveals safety concerns about peptides used for tendon repair and athletic enhancement. Critical insights for healthcare providers and patients.
By Peptide Association Research Team
Breakthrough research reveals enhanced bioavailability of peptide minerals through innovative encapsulation technology. Learn what this means for therapy.
By Peptide Association Research Team
Breakthrough study reveals SS-31 mitochondrial peptide therapy combined with NMN shows promise for sarcopenia treatment. Learn about NAD peptide therapy advances.
By Peptide Association Research Team
Groundbreaking study reveals how spray-drying optimization improves peptide suspension stability for therapeutic applications including tendon repair.
By Peptide Association Research Team
New research reveals stable peptide formulation methods for glatiramer acetate nanoparticles, advancing peptide therapy manufacturing and storage solutions.
By Peptide Association Research Team
New research examines cost-effectiveness of diabetes medications. Learn about peptide therapy regulation and safety considerations for healthcare providers.
By Peptide Association Research Team
Breakthrough study reveals self-assembling peptide hydrogels enhance nerve regeneration when combined with stem cells. Learn about this promising research.
By Peptide Association Research Team
Groundbreaking research reveals next-generation GLP-1 peptide therapies targeting multiple receptors for enhanced diabetes and obesity treatment outcomes.
By Peptide Association Research Team
Latest longevity peptide research explores probiotic connections to aging populations. Learn what this means for peptide therapy and clinical practice.
By Peptide Association Research Team
New research reveals how MAPK p38α inhibition overcomes FPR1 mutations affecting immune surveillance. Learn about peptide therapy implications.
By Peptide Association Research Team
Recent study reveals diammonium glycyrrhizinate and vitamin D3 combination may help treat pulmonary fibrosis through novel mechanisms. Learn about the research.
By Peptide Association Research Team
New FDA study reveals higher adverse events in compounded GLP-1 peptides vs commercial versions. Important safety insights for peptide therapy providers.
By Peptide Association Research Team